Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fogel

Showing results (201-210 of 203) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 203 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2018
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J Palumbo, Jessica M Fogel, Sarah E Hudelson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 18, 2016
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
Pageof 21

Showing results (201-210 of 203) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 203 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2018
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J Palumbo, Jessica M Fogel, Sarah E Hudelson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 18, 2016
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
Pageof 21